Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Arcadia Biosciences (RKDA) Return on Sales (2016 - 2025)

Arcadia Biosciences (RKDA) has disclosed Return on Sales for 12 consecutive years, with 0.89% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Sales fell 61.0% year-over-year to 0.89%, compared with a TTM value of 0.33% through Sep 2025, down 79.0%, and an annual FY2024 reading of 0.54%, down 36.0% over the prior year.
  • Return on Sales was 0.89% for Q3 2025 at Arcadia Biosciences, down from 0.34% in the prior quarter.
  • Across five years, Return on Sales topped out at 6.23% in Q4 2023 and bottomed at 6.44% in Q1 2021.
  • Average Return on Sales over 5 years is 1.1%, with a median of 0.89% recorded in 2025.
  • The sharpest move saw Return on Sales skyrocketed 3137bps in 2021, then crashed -626bps in 2024.
  • Year by year, Return on Sales stood at 3.74% in 2021, then skyrocketed by 105bps to 0.18% in 2022, then soared by 3401bps to 6.23% in 2023, then plummeted by -100bps to 0.02% in 2024, then crashed by -4042bps to 0.89% in 2025.
  • Business Quant data shows Return on Sales for RKDA at 0.89% in Q3 2025, 0.34% in Q2 2025, and 0.24% in Q1 2025.